1. HumaPen Ergo®: A New 3.0 ml Reusable Insulin Pen

   • Alan Stocks
   • S. R. Perry
   • P. Brydon

   Clinical Use 24 August 2012 Pages: 319 - 324

   

2. Effect of Cilostazol on Lipid, Uric Acid and Glucose Metabolism in Patients with Impaired Glucose Tolerance or Type 2 Diabetes Mellitus

   • Takayoshi Toyota
   • Shinichi Oikawa
   • Akira Fukao

   Clinical Pharmacodynamics 24 August 2012 Pages: 325 - 335

   

3. Effects of Losartan on the Renin-Angiotensin-Aldosterone System and Erythrocytosis in Patients with Chronic Obstructive Pulmonary Disease and Systemic Hypertension

   • A. Füsun Ülger
   • Özlem Özdemir Kumbasar
   • Doganay Alper

   Clinical Pharmacodynamics 24 August 2012 Pages: 337 - 343

   

4. Lack of Interaction between Pantoprazole and Ethanol

   • H. Heinze
   • R. Fischer
   • M. V. Singer

   Clinical Pharmacokinetics 24 August 2012 Pages: 345 - 351

   

5. Azithromycin Concentrations in Serum and Bronchial Secretions of Patients with Cystic Fibrosis

   • Marco Cipolli
   • Giantonio Cazzola
   • Teresita Mazzei

   Clinical Pharmacokinetics 24 August 2012 Pages: 353 - 360

   

6. Comparative Bioavailability Study of Two Different Nimesulide-Containing Preparations Available on the Italian Market

   • V. Hutt
   • J. Waitzinger
   • F. Macchi

   Clinical Pharmacokinetics 24 August 2012 Pages: 361 - 369

   

7. Comparative Plasmodium falciparum Kinetics during Treatment with Amodiaquine and Chloroquine in Children

   • A. Sowunmi
   • A. G. Falade
   • A. M. J. Oduola

   Clinical Pharmacokinetics 24 August 2012 Pages: 371 - 381

   

8. Comparative Single-Dose Bioavailability Study of Two Oral Formulations of Ibuprofen in Healthy Volunteers

   • A. Portolés
   • E. Vargas
   • A. Moreno

   Clinical Pharmacokinetics 24 August 2012 Pages: 383 - 389